UnitedHealth's Surge: Examining Berkshire Hathaway's Investment

Since Berkshire Hathaway revealed in August that it had invested in UnitedHealth between April and June, the stock has climbed nearly 30%.

Before the news, UnitedHealth closed at $271.49, and by Friday, its value rose to $352.51.

UnitedHealth had begun to recover from its annual low of $237.77 on August 1. Much of its recent success is attributed to Berkshire Hathaway's endorsement.

However, it's uncertain whether Berkshire's investment is currently profitable when valuing on paper. The price has increased by only 13% since it reached $311.97 at the close of the second quarter.

Estimating the precise timing of Berkshire's purchases during the second quarter is challenging, leaving room for speculation about the possible price range.

Considering a hypothetical purchase at the quarter's peak of $606.36 per share, Berkshire might have faced a loss of 42%. Conversely, at the low of $248.88, it would result in a 42% gain.

The average trading price during this period suggests a Berkshire expenditure of $1.9 billion, while the current stock value of $1.8 billion lags this by approximately 8%.

Early-quarter price declines likely prompted Berkshire's buying spree, possibly putting their entry price at the lower end, yet potential red ink looms.

Despite the tumult, Berkshire typically invests for the long term. Signs for UnitedHealth, down 30% for the year, seem optimistic.

Following meetings with UnitedHealth executives, Morgan Stanley analysts expressed increased positivity about the company's future.

On Friday, Erin Wright from Morgan Stanley adjusted her price target for UnitedHealth from $325 to $395.

Jim Cramer on CNBC suggested buyer caution but mentioned that some investors sense that the stock's worst days are over.

Kraft Heinz Faces Challenges Amid Berkshire's Interest

Anticipations for an increased Berkshire stake in Kraft Heinz don't look as promising.

Kraft Heinz's shares plummeted by another 4.25% this week after a 2% drop last week, driven by its turnaround strategy.

In a rare move contradicting passive investment practices, the company proceeded despite the objections of its largest shareholder.

Don Bilson of Gordon Haskett noted that aside from doubts over the plan, investors worry Berkshire might now sell its shares.

Any sales over 10% stake would need public disclosure within two business days, causing concern among investors.

Buffett Slips in Forbes 400 Hierarchy

Warren Buffett's rank fell on the Forbes list of the wealthiest Americans, though his net worth held steady at $150 billion.

Despite a near 10% rise in the value of Berkshire shares, his primary asset, Buffett's donations to the Gates Foundation affected his standings.

Since 2006, had Buffett retained his donations, his fortune would approximate $350 billion, placing him second to top billionaires.

Recent increases in other tech shares, however, have shifted the tier rankings, impacting his position.

In hypothetical real-time rankings, he'd be closely matched with top billionaires, although Elon Musk remains significantly ahead.